Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

25
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
25
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Angina V: Nursing Management01:20

Angina V: Nursing Management

43
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
43
Angina II: Classification01:27

Angina II: Classification

38
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
38
Angina IV: Management01:26

Angina IV: Management

22
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
22
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 心血管医学と血液学
  5. 心臓病 (心血管疾患を含む)
  6. 非阻害性冠動脈における冠動脈動脈機能不全の臨床的有用性
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 心血管医学と血液学
  5. 心臓病 (心血管疾患を含む)
  6. 非阻害性冠動脈における冠動脈動脈機能不全の臨床的有用性

関連する実験動画

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K

非阻害性冠動脈における冠動脈動脈機能不全の臨床的有用性

Kai Nogami1, Lilach O Lerman1,2, Amir Lerman1

  • 1Department of Cardiovascular Medicine.

Current opinion in cardiology
|September 1, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

閉塞性冠動脈疾患 (ANOCA) のない胸痛における冠動脈機能障害 (CVDys) は,より悪い結果と関連しています. 冠動脈反応性検査 (CRT) を用いた総合的な評価は,主要な心血管疾患のリスクの分層化を助けます.

キーワード:
胸痛と非閉塞性冠動脈冠動脈反応性検査冠動脈動脈機能障害

さらに関連する動画

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

3.7K
Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

15.9K

関連する実験動画

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

3.7K
Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

15.9K

科学分野:

  • 心臓病科
  • 血管生物学
  • 臨床研究

背景:

  • 冠動脈機能不全 (CVDys) は,閉塞性冠動脈疾患 (ANOCA) がない患者の胸痛に寄与する.
  • 異なるCVDysサブタイプの予後的な影響を理解することは,患者の管理に極めて重要です.
  • 最近の大規模な研究により,ANOCAにおけるCVDysに関する新しい洞察が得られました.

研究 の 目的:

  • ANOCAでのCVDysの現在の理解をレビューする.
  • CVDysのサブタイプと予後に関する包括的な研究の結果について議論します.
  • 将来の研究と臨床実践の方向性を探す

主な方法:

  • ANOCAにおけるCVDysに関する現在の文献のレビュー.
  • CVDysのサブタイプに関する最近の大規模な研究結果の分析
  • CVDysの評価のための冠動脈反応性検査 (CRT) の評価

主要な成果:

  • CVDysは,上心動脈または微小血管動脈の血管収縮/血管拡張の障害を伴う.
  • ANOCAでは,内皮に依存した表心機能障害と微血管機能障害の両方が,より悪い予後に関連しています.
  • 微小血管機能 (内皮に依存し,内皮に依存しない) は,主要な心血管疾患の独立予測因子である.
内皮の機能
マイクロ血管機能障害

結論:

  • ANOCAにおけるCVDysの予後効果に関する証拠は増えています.
  • ANOCAにおけるCVDysの効果的な治療戦略はまだ必要である.
  • 将来の研究は,臨床的結果を改善するためのCRTによる介入に焦点を当てるべきです.